Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. LYB
7. TFII
8. SPY
9. AAPL
10. MRVL

Go back to Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 17c

Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results

November 5, 2020 4:01 PM EST

U.S. QINLOCK® Net Revenue of $14.7 Million in the First Full Quarter of Launch

Marketing Authorisation Application for QINLOCK in Fourth-line GIST Validated by the European Medicines Agency; Commercial Planning for Europe Underway

Enrollment for QINLOCK Phase 3 INTRIGUE Study Expected to be Completed in Fourth Quarter 2020

DCC-3014 Phase 1 Study Results in Additional TGCT Patients to be Featured in an Oral Presentation at the CTOS 2020 Virtual Annual Meeting

Company to Host Conference Call Today at 4:30 PM ET

WALTHAM, Mass.--(BUSINESS... More